Upcoming Webinar
Aventa Lymphoma: Robust Genome Wide Fusion and Rearrangement Detection, a Modern Alternative to FISH for Diagnostic Testing
Provide your email and be the first to know when dates are scheduled in early 2026 for this exciting webinar where experts in lymphoma will share their experiences with Aventa Lymphoma.
Speakers
Ying S. Zou, MD, PhD, FACMG (she/her/hers)
Director of Cancer Genetic Laboratory
The Johns Hopkins University
Anthony Schmitt, PhD
SVP of Science
Arima Genomics
Adam Smith, PhD, FCCMG, FACMG, erCLG
Clinical Laboratory Director, Cytogenetics Center for Molecular Biology and Pathology
Labcorp
Matija Snuderl, MD (he/him/his)
Director of Molecular Pathology
NYU Langone Health
Aventa Lymphoma is a clinically validated lab developed test that leverages Hi-C sequencing to detect all clinically relevant fusions and rearrangements in B- and T-cell lymphomas. This webinar will provide an overview of test technology as well as the clinical experience of three practicing pathologists who have utilized the test, including their results on comparison with clinical FISH, deconvolution of atypical FISH results, and clinical case studies.